These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15781028)

  • 1. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.
    Dulin BR; Haas SJ; Abraham WT; Krum H
    Am J Cardiol; 2005 Apr; 95(7):896-8. PubMed ID: 15781028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker therapy in heart failure in the elderly.
    Fu M
    Int J Cardiol; 2008 Apr; 125(2):149-53. PubMed ID: 18023898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
    Haas SJ; Vos T; Gilbert RE; Krum H
    Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers in elderly with heart failure].
    Scherillo M; D'Andrea A; Tesorio MG; Pulignano G
    Ital Heart J Suppl; 2000 Aug; 1(8):1027-30. PubMed ID: 10993009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
    Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure in elderly patients.
    Spiecker M
    Exp Gerontol; 2006 May; 41(5):549-51. PubMed ID: 16621389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic blockers for chronic heart failure.
    Javed U; Deedwania PC
    Cardiol Rev; 2009; 17(6):287-92. PubMed ID: 19829179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-blockers in the treatment of chronic heart failure.
    Kubon C; Mistry NB; Grundvold I; Halvorsen S; Kjeldsen SE; Westheim AS
    Trends Pharmacol Sci; 2011 Apr; 32(4):206-12. PubMed ID: 21376403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H; Haas SJ; Eichhorn E; Ghali J; Gilbert E; Lechat P; Packer M; Roecker E; Verkenne P; Wedel H; Wikstrand J
    Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A continued role for beta-blocker therapy in heart failure.
    Korczyk DP; Doughty RN
    Heart Fail Monit; 2006; 5(1):15-9. PubMed ID: 16547531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
    Chan JD; Rea TD; Smith NL; Siscovick D; Heckbert SR; Lumley T; Chaves P; Furberg CD; Kuller L; Psaty BM
    Am Heart J; 2005 Sep; 150(3):464-70. PubMed ID: 16169325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-adrenoceptor antagonists in the treatment of chronic heart failure].
    Bundkirchen A; Brixius K; Schwinger RH
    Pharmazie; 2004 Feb; 59(2):83-92. PubMed ID: 15025174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocker tolerability in elderly heart failure patients.
    Düngen HD; Mehrhof F; Apostolović S; Inkrot S; Dietz R
    Int J Cardiol; 2009 Jul; 136(1):93-4; author reply 94-5. PubMed ID: 18602708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
    Tabet JY; Metra M; Thabut G; Logeart D; Cohen-Solal A
    Am J Cardiol; 2006 Aug; 98(4):500-3. PubMed ID: 16893705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure.
    Parameswaran AC; Tang WH; Francis GS; Gupta R; Young JB
    Am Heart J; 2005 May; 149(5):921-6. PubMed ID: 15894978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B; Kjörk E; Brunlöf G
    Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.